Covid-19 testing supplies

Active Awarded Last action

Contract number
HT001426FE004
Awardee
Awarding agency
Obligated
$914,983

Award facts

Contract value 100% obligated
$914,982.50 Current and potential, with all options
Completion date 79% complete
Current and potential, with all options
Contracting staff
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Belvoir, VA 22060, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Cepheid Inc. for COVID-19 testing supplies with a ceiling value of $914,982.50 under a firm fixed-price contract structure. The award, executed on January 8, 2026, with an ultimate completion date of January 7, 2027, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. Performance will take place at Fort Belvoir, Virginia, and the contract includes no set-aside designation, reflecting Cepheid's competitive positioning in the federal diagnostics procurement market. This BPA call leverages Cepheid's core competency in providing rapid molecular diagnostic testing capabilities and associated reagents and test kits for infectious disease detection.

This award builds upon Cepheid's extensive portfolio of federal contracts with the Defense Health Agency and other military medical centers, where the company has provided equipment maintenance services, full-service agreements for GeneXpert diagnostic systems, and RT-PCR analyzer support. The company's federal presence extends across multiple agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency Medical Supply Chain, with contract values ranging from modest service orders to multi-million dollar agreements. The COVID-19 testing supplies contract directly supports the Defense Health Agency's operational requirements for diagnostic capabilities across military medical facilities and represents continued federal reliance on Cepheid's molecular diagnostic platform and associated testing solutions.

Quick answers

Who was awarded contract HT001426FE004?

HT001426FE004 was awarded to Cepheid by Defense Health Agency (Department of Defense) on January 8, 2026.

How much is contract HT001426FE004 worth?

The government has obligated $914,983 on HT001426FE004.

Is contract HT001426FE004 an order under another contract?

Yes. HT001426FE004 is a BPA call under HT001425A0002, a blanket purchase agreement.

Was contract HT001426FE004 competed?

The extent of competition for HT001426FE004 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award